SCTX Scribe Therapeutics Inc.

Fundamentals / CIK 0001853921 / USD

Scribe Therapeutics Inc. reported $187.9M in total assets through September 30, 2026 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open SCTX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

No annual income statement rows are available in SEC EDGAR CompanyFacts for SCTX.

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-09-30 2025-06-30 2025-03-31
Revenue $1.64M $1.92M -- $20.11M $4.90M --
Research & Development $8.26M $8.82M -- $14.42M $13.88M --
Total Operating Expenses $12.50M $11.31M -- $17.95M $16.52M --
Operating Income -$10.86M -$9.39M -- $2.16M -$11.63M --
EBITDA -$10.26M -$8.79M -- $2.86M -$10.93M --
Interest Expense $0 $276K -- $598K $598K --
Income Before Tax -$9.63M -$6.26M -- $1.80M -$10.62M --
Income Tax Expense $231K $212K -- $324K -$712K --
Net Income -$9.86M -$6.48M -$17.35M $1.47M -$9.90M -$3.42M
Basic EPS -$0.68 -$2.62 -- $0.00 -$4.08 --
Diluted EPS -$0.68 -$2.62 -- $0.00 -$4.08 --
Basic Shares Outstanding 14.5M 2.5M -- 2.4M 2.4M --
Diluted Shares Outstanding 14.5M 2.5M -- 2.4M 2.4M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

No annual balance sheet rows are available in SEC EDGAR CompanyFacts for SCTX.

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2025-12-31
Cash & Cash Equivalents $172.1M $35.59M $12.80M
Short-Term Investments $2.18M $7.42M $45.17M
Cash & Short-Term Investments $174.2M $43.00M $58.00M
Total Current Assets $178.9M $45.10M $66.93M
Property, Plant & Equipment, Net $5.15M $5.75M $7.01M
Other Non-Current Assets $586K $3.61M $538K
Total Non-Current Assets $9.04M $12.82M $11.29M
Total Assets $187.9M $57.93M $78.22M
Accounts Payable $2.77M $2.77M $4.57M
Deferred Revenue (Current) $25.42M $27.48M $21.09M
Total Current Liabilities $37.93M $78.70M $69.06M
Deferred Revenue (Non-Current) $12.95M $11.70M $19.94M
Other Non-Current Liabilities $8.15M $7.92M $7.49M
Total Non-Current Liabilities $24.83M $23.72M $32.23M
Total Liabilities $62.76M $102.4M $101.3M
Total Debt (incl. Leases) $5.14M $5.47M $6.09M
Common Stock $36K $14K $14K
Retained Earnings -$191.4M -$181.5M -$157.7M
Accumulated Other Comp. Income $0 -$2.0K $35K
Total Stockholders' Equity $125.2M -$164.8M -$143.4M
Total Equity $125.2M -$164.8M -$143.4M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

No annual cash flow statement rows are available in SEC EDGAR CompanyFacts for SCTX.

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-09-30 2025-06-30 2025-03-31
Net Income -$9.86M -$6.48M -$17.35M $1.47M -$9.90M -$3.42M
Depreciation & Amortization $600K $600K -- $700K $700K --
Stock-Based Compensation $1.22M $227K -- $2.23M $676K --

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

No annual ratios & growth rows are available in SEC EDGAR CompanyFacts for SCTX.

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-09-30 2025-06-30 2025-03-31
Current Ratio 4.72x 0.57x -- -- -- --
Quick Ratio 4.59x 0.55x -- -- -- --
Debt to Equity 0.04x -- -- -- -- --
Revenue Growth (YoY) -91.9% -60.8% -- -- -- --
Operating Income Growth (YoY) -602.6% -- -- -- -- --
Net Income Growth (YoY) -770.0% -- -- -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001853921) · from March 31, 2025 Data through September 30, 2026 · synced Nov 20, 2026, 05:41 UTC · Open in terminal